Older Adults Face Four Vaccine Decisions This Fall While the Federal Schedule Still Carries a 2025 Date - Medical Daily

Latest News About Next-generation flu shot gets a new development partnership

Osivax and GC Biopharma announced a major partnership focused on developing a more advanced influenza vaccine. The vaccine aims to combine OVX836 and GC FLU. Osivax obtained the rights for pursuing a combination shot.

Older adults are facing four vaccine decisions this fall, while the federal schedule continues to carry a 2025 date. Flu and pneumonia deaths have fallen for 25 years, but one American age group posted an uptick.

Sources & References